1028eTiP DiscovHER PAN-206: Phase II tumour-agnostic study of zanidatamab in patients with previously treated human epidermal growth factor receptor 2 (HER2)-overexpressing solid tumours.
Saved in:
| Title: | 1028eTiP DiscovHER PAN-206: Phase II tumour-agnostic study of zanidatamab in patients with previously treated human epidermal growth factor receptor 2 (HER2)-overexpressing solid tumours. |
|---|---|
| Authors: | Subbiah, V.1 (AUTHOR), Makker, V.2 (AUTHOR), Oh, D-Y.3 (AUTHOR), Gardener, E.4 (AUTHOR), Gartner, E.5 (AUTHOR), Meric-Bernstam, F.6 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS667-S668. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.1597 |
